Marya Lieberman

5.7k total citations · 1 hit paper
117 papers, 4.4k citations indexed

About

Marya Lieberman is a scholar working on Molecular Biology, Biomedical Engineering and Electrical and Electronic Engineering. According to data from OpenAlex, Marya Lieberman has authored 117 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 37 papers in Biomedical Engineering and 36 papers in Electrical and Electronic Engineering. Recurrent topics in Marya Lieberman's work include Advanced biosensing and bioanalysis techniques (28 papers), Biosensors and Analytical Detection (24 papers) and Molecular Junctions and Nanostructures (22 papers). Marya Lieberman is often cited by papers focused on Advanced biosensing and bioanalysis techniques (28 papers), Biosensors and Analytical Detection (24 papers) and Molecular Junctions and Nanostructures (22 papers). Marya Lieberman collaborates with scholars based in United States, Kenya and Ethiopia. Marya Lieberman's co-authors include Yuliang Wang, Craig S. Lent, Gary H. Bernstein, Tomikazu Sasaki, K. Sarveswaran, Walter Hu, C. Sudha, Yi Wang, Kirk S. Schanze and R. A. Marcus and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Marya Lieberman

115 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Charge Transfer on the Nanoscale: Current Status

2003 872 citations Marya Lieberman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marya Lieberman United States	31	2.0k	1.0k	993	910	718	117	4.4k
Mathew D. Halls United States	34	2.0k 1.0×	707 0.7×	2.5k 2.6×	622 0.7×	903 1.3×	104	5.7k
Majid Monajjemi Iran	39	1.3k 0.6×	539 0.5×	1.9k 1.9×	628 0.7×	264 0.4×	373	4.9k
Ganesh Kamath United States	33	969 0.5×	824 0.8×	1.4k 1.4×	521 0.6×	611 0.9×	127	3.8k
Ye Mei China	38	491 0.2×	439 0.4×	881 0.9×	1.8k 2.0×	851 1.2×	192	4.1k
José R. B. Gomes Portugal	50	877 0.4×	1.1k 1.1×	4.8k 4.8×	404 0.4×	939 1.3×	285	8.1k
Xiao‐Shun Zhou China	27	2.3k 1.2×	2.0k 2.0×	2.1k 2.1×	1.4k 1.5×	951 1.3×	138	5.9k
L.A. Dı́az-Torres Mexico	37	1.6k 0.8×	1.7k 1.7×	3.9k 4.0×	1.3k 1.5×	295 0.4×	150	7.9k
Hai‐Feng Ji United States	39	1.8k 0.9×	1.1k 1.1×	1.6k 1.6×	930 1.0×	1.4k 2.0×	224	5.7k
Wolfgang Haiss United Kingdom	30	3.2k 1.6×	2.0k 2.0×	2.2k 2.2×	1.5k 1.6×	1.8k 2.5×	44	6.6k
Jin‐Liang Wang China	50	5.0k 2.5×	764 0.8×	3.5k 3.5×	301 0.3×	235 0.3×	198	9.1k

Countries citing papers authored by Marya Lieberman

Since Specialization

Citations

This map shows the geographic impact of Marya Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marya Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marya Lieberman more than expected).

Fields of papers citing papers by Marya Lieberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marya Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marya Lieberman. The network helps show where Marya Lieberman may publish in the future.

Co-authorship network of co-authors of Marya Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Marya Lieberman. A scholar is included among the top collaborators of Marya Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marya Lieberman. Marya Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ashenef, Ayenew, Atalay Mulu Fentie, Ibrahim Chikowe, et al.. (2025). Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation. The Lancet Global Health. 13(7). e1250–e1257.

Frederick, Kimberley A., et al.. (2025). Bridging the Science Practices Gap: Analyzing Laboratory Materials for Their Opportunities for Engagement in Science Practices. Journal of Chemical Education. 102(3). 970–983. 2 indexed citations

Cai, Jin, et al.. (2024). Field assessment of active ingredient quantity in pharmaceutical tablets with limited calibration of near infrared spectra: An application to ciprofloxacin tablets. Journal of Pharmaceutical and Biomedical Analysis. 246. 116189–116189. 1 indexed citations

Braegelman, Adam S., et al.. (2024). Capture and Detection of Fentanyl with Thiolated Cucurbit[7]uril Macrocycles on Silver Nanoparticles. ACS Applied Nano Materials. 7(9). 10879–10885. 5 indexed citations

Fernando, H. J. S., et al.. (2024). A lot testing protocol for quality assurance of fentanyl test strips for harm reduction applications. Harm Reduction Journal. 21(1). 152–152. 2 indexed citations

Wicks, A C, et al.. (2024). Mitigating the impact of gelatin capsule variability on detection of substandard and falsified pharmaceuticals with near-IR spectroscopy. Analytical Methods. 16(11). 1611–1622. 2 indexed citations

Lieberman, Marya, et al.. (2024). An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America. Harm Reduction Journal. 21(1). 115–115. 4 indexed citations

Whitehead, Heather D., et al.. (2023). Validated method for the analysis of 22 illicit drugs and their metabolites via liquid chromatography tandem mass spectrometry (LC-MS/MS) in illicit drug samples collected in Chicago, IL. Forensic Chemistry. 33. 100475–100475. 14 indexed citations

Sacré, Pierre‐Yves, Raffaella Ravinetto, Marya Lieberman, et al.. (2023). Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance. PLoS ONE. 18(8). e0289865–e0289865. 7 indexed citations

10.

Whitehead, Heather D., et al.. (2023). Development and validation of a liquid chromatography tandem mass spectrometry method for the analysis of 53 benzodiazepines in illicit drug samples. Forensic Chemistry. 35. 100512–100512. 5 indexed citations

11.

Oliver, Allen G., et al.. (2023). Bis(N,N-diethyl-4-methyl-4-piperazine-1-carboxamide) tetrakis(isothiocyanato-κN)cobalt(II), a model compound for the blue color developed in the Scott test. Acta Crystallographica Section E Crystallographic Communications. 79(3). 163–166. 2 indexed citations

12.

Meyers, Natalie, et al.. (2022). Securing the Chain of Custody and Integrity of Data in a Global North-South Partnership to Monitor the Quality of Essential Medicines. SHILAP Revista de lepidopterología. 5. 1 indexed citations

13.

Tighe, Meghanne, et al.. (2021). Screening for Per- and Polyfluoroalkyl Substances in Water with Particle Induced Gamma-Ray Emission Spectroscopy. ACS ES&T Water. 1(12). 2477–2484. 22 indexed citations

14.

Huynh, Philip, et al.. (2021). Community overdose surveillance: Comparing substances collected from the death scene investigation to toxicology results. Drug and Alcohol Dependence. 224. 108722–108722. 16 indexed citations

15.

Merga, Getahun, et al.. (2020). idPAD: Paper Analytical Device for Presumptive Identification of Illicit Drugs. Journal of Forensic Sciences. 65(4). 1289–1297. 28 indexed citations

16.

Tighe, Meghanne, et al.. (2020). A Sensitive XRF Screening Method for Lead in Drinking Water. Analytical Chemistry. 92(7). 4949–4953. 22 indexed citations

17.

Tighe, Meghanne, et al.. (2019). Risky bismuth: Distinguishing between lead contamination sources in soils. Chemosphere. 234. 297–301. 6 indexed citations

18.

Lieberman, Marya, et al.. (2017). Green design of a paper test card for urinary iodine analysis. PLoS ONE. 12(6). e0179716–e0179716. 5 indexed citations

19.

Tran, Dan N., Benson Njuguna, I Manji, et al.. (2016). Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening. Cardiology Clinics. 35(1). 125–134. 15 indexed citations

20.

Yun, Je Moon, Ju Young Kim, Dong Ok Shin, et al.. (2011). DNA Origami Nanopatterning on Chemically Modified Graphene. Angewandte Chemie International Edition. 51(4). 912–915. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact